摘要
目的:探讨数字化俯卧式X线定位系统下Mammotome微创切除不可触及乳腺病灶在乳腺癌早期诊断的临床应用价值.方法:2004年12月～2005年5月,应用IORAD数字化俯卧式穿刺床X线立体定位系统引导下Mammotome系统对67例患者73个临床不可触及乳腺钼靶X线片表现为可疑病灶进行微创切除活检.73个病灶中X线摄片:42例为孤立簇状聚集钙化,27例为不规则致密影并簇状钙化,4例为局部腺体结构扭曲.术前BIRADS评级Ⅲ、Ⅳ和Ⅴ级分别为51、1 7和5个.结果:67例患者73个病灶,乳腺癌1 3个(1 7.8%),其中4个为乳腺导管内癌.3个导管内癌并早期浸润.6个浸润性导管癌.良性病变60个(82.1%).13个乳腺癌术后分期:2个为0期.9个为Ⅰ期.2个为ⅡA期.13个中11个为早期乳腺癌(84.6%).结论:应用LORAD数字化俯卧式X线立体定位系统引导下Mammotome系统微创活检不可触及乳腺X线摄片发现的微小病灶.是一种确诊早期乳腺癌的微创方法.
OBJECTIVE：To assess the benefits of stereotactic vacuum-assisted breast biopsy in patients with non-palpable lesions detected on marnmography. METHODS： Between November 2004 and May 2005, stereotactic Mammotome biopsies were performed for 73 non-palpable lesions on marnmography by using by the prone-type stereotactic vacuurrrassisted breast biopsy system （Marnmotome. Ethicon Endosurgery USA; The prone-table, LORAD USA）. The mammography findings were classified according to the guidelines of The American College of Radiology BIRADS. Fifty-one cases were category 3, 17 were category 4, and 5 were category 5. RESULTS： Seventy-three of the cases were mastopathy, and 13 of them were breast cancer （4 were ductal carcinoma in situ, 3 were ductal carcinoma in situ with microinvasion, and 6 were invasive ductal carcinoma）. The post-operative Stages of 13 cases were as follows： 2 were Stage 0. 9 were Stage 1, and 2 were Stage 2A. Thirteen of 11 （81.6%） were early breast cancers. CONCLUSIONS： Stereotactic biopsy （Mammotome） is a safe and useful modality for the histological diagnosis of non-palpable microcalcifications to detect early breast cancer.
出处
《肿瘤防治杂志》
2005年第16期1255-1258,共4页
China Journal of Cancer Prevention and Treatment
作者简介
廖宁,女,广东紫金人,法国DESS,主治医师,主要从事乳腺外科专业的研究工作.Tel：86-20-83827812-45090 E-mail：drliao_nmg@hotmail.com .
吴一龙,男,广东汕头人,主任医师,博士生导师,主要从事肺癌多学科综合治疗及肿瘤循征医学的研究工作.Tel：86-20-83821484 E mail：gzyilong@hotmail.com.
